SCHEMBL25818458

SCHEMBL25818458

Clc1nc(-c2cccc(-c3ccc4c(-c5ccccc5)cccc4c3)c2)nc(-c2ccc3oc4ccccc4c3c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
PLA2G10 O15496 1/20 0.39
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
AHR P35869 2/20 0.37
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 5/20 0.36
HSD17B10 Q99714 3/20 0.36
ATM Q13315 2/20 0.36
RAB9A P51151 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 4/20 0.35
HPGD P15428 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818478 0.93 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL25818412 0.92 HSD17B1 (0.36) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL25818523 0.92 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL25817762 0.91 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23633504 0.91 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL25818522 0.90 HSD17B1 (0.36) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL25132563 0.89 PIM1 (0.38) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL22161126 0.89 ALDH1A1 (0.39) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL24949978 0.88 MAPT (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL25818465 0.88 ALDH1A1 (0.40) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 PLA2G2A 4355/4885PLA2G4A 3970/4885PLA2G10 4127/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 PLA2G2A 4355/4885PLA2G4A 3970/4885PLA2G10 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.